Agonist and antagonist actions of antipsychotic agents at 5-HT1A receptors: a []GTPγS binding study

Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding

Alain Schotte, Paul Janssen, W Gommeren et al. · Psychopharmacology · 1996 · 1.2K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +11

Radioreceptor Binding Profile of the Atypical Antipsychotic Olanzapine

Frank P. Bymaster, David O. Calligaro, Julie F. Falcone et al. · Neuropsychopharmacology · 1996 · 1.1K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10

Drugs and the treatment of psychiatric disorders

R. J. Baldessarini · Medical Entomology and Zoology · 1996 · 688 citations

Pharmacy, Pharmacotherapy, Psychiatry +12

Characterization of the 5-hydroxytryptamine1a receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in guinea pig and rat hippocampal membranes.

Michael De Vivo, Saul Maayani · Journal of Pharmacology and Experimental Therapeutics · 1986 · 424 citations

Medicine, Neurobiology, Pharmacology +15

Ziprasidone (CP-88,059): a new antipsychotic with combined dopamine and serotonin receptor antagonist activity.

Thomas Seeger, P A Seymour, Anne W. Schmidt et al. · Journal of Pharmacology and Experimental Therapeutics · 1995 · 322 citations

Medicine, Pharmacology, Pharmacotherapy +15